Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial.
Bryant RJ. et al, (2025), Lancet Oncol, 26, 583 - 595
Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10-year single-centre cohort.
Anbarasan T. et al, (2024), BJUI Compass, 5, 834 - 836
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy.
Hamdy FC. et al, (2024), Eur J Nucl Med Mol Imaging, 51, 3009 - 3025
Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease.
Charlton PV. et al, (2024), Prostate, 84, 977 - 990
New role of fat-free mass in cancer risk linked with genetic predisposition.
Harris BHL. et al, (2024), Sci Rep, 14
Enhancing novel multimodality therapy for prostate cancer, combining radiotherapy, vascular-targeted photodynamic therapy, and anti-CD73 immunotherapy
Sjoberg HT. et al, (2024), EUROPEAN UROLOGY, 85, S2204 - S2204
Investigating the STING pathway in the prostate cancer tumour immune microenvironment and radiosensitivity
Chan CY. et al, (2024), EUROPEAN UROLOGY, 85, S2205 - S2205
Spatial transcriptomic clonal deconvolution identifies the lethal clone in Prostate Cancer (PCa) as defined by ability to metastasize to lymph nodes
Yin W. et al, (2024), EUROPEAN UROLOGY, 85, S1668 - S1669
Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.
Rao SR. et al, (2023), Int J Mol Sci, 24
Geometric Anatomy Basis for Safe and Effective Focal Ablation of Prostate Cancer by Irreversible Electroporation (IRE)
Cussenot O. et al, (2023), Anatomia, 2, 232 - 242
Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique.
Bryant RJ. et al, (2023), BJU Int, 131, 694 - 704
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
Hamdy FC. et al, (2023), N Engl J Med, 388, 1547 - 1558
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment.
Donovan JL. et al, (2023), NEJM Evid, 2
Same day discharge robot‐assisted laparoscopic prostatectomy ‐ feasibility, safety & patient experience
Hill GT. et al, (2023), BJU International